stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
무료 - Play StoreApp Store
설치하다설치하다
logo
Supernus Pharmaceuticals IncSUPN
$30.4827.29%-11.44

Supernus Pharmaceuticals Inc (SUPN)

Date: 2026-11-03 16:00O: 28.35H: 31.20L: 28.35C: 30.48Vol: 948.6k
전일 마감가:
$41.92
열려 있는:
$28.35
하루 거래량:
980,487
상대 거래량:
0.72
시가총액:
$1.78B
수익:
$776.83M
순이익/손실:
-$29.02M
주가수익비율:
-
EPS:
-$0.512
순현금흐름:
$82.25M
1W 성능:
-25.59%
1M 성능:
-28.08%
6M 성능:
-36.30%
1Y 성능:
-45.28%
1일 변동 폭
$28.35$31.20
1주일 범위
$39.53$44.31
52주 변동 폭
$28.35$59.68

Supernus Pharmaceuticals Inc 주식 (SUPN) 회사 개요

명칭
Supernus Pharmaceuticals Inc
전화
301-838-2500
주소
9715 KEY WEST AVENUE, ROCKVILLE, MD, USA
직원
778
다음 수익 날짜
null
최신 SEC 제출 서류
SEC
X에서 SUPN에 대한 토론
X

 

시가총액

 

매출

 

순이익

 

현금흐름

 

주당 순 이익

 

Supernus Pharmaceuticals Inc 주식(SUPN) 업그레이드 및 다운그레이드

날짜액션분석자등급 변경
2025-10-09업그레이드Piper SandlerNeutral → Overweight
2025-07-30업그레이드Cantor FitzgeraldNeutral → Overweight
2025-02-19다운그레이드Cantor FitzgeraldOverweight → Neutral
2025-01-06개시Cantor FitzgeraldOverweight

Supernus Pharmaceuticals Inc (SUPN) 재무 분석

기간추세FY 2025FY 2024FY 2022FY 2021FY 2020
기간 종료일2025-12-312024-12-312023-12-312021-12-312020-12-31
Revenue USD (M)718.95661.82667.24579.78520.40
Cost of revenue USD (M)74.5677.91--52.46
Gross profit USD (M)----467.94
Research and development USD (M)106.24108.8074.5590.4775.96
Operating expenses USD (M)781.24580.15621.11493.75294.24
Operating income USD (M)-62.2881.6746.1286.03173.70
Income before tax USD (M)-49.0397.8760.7473.18168.65
Income tax expense USD (M)-10.4824.010.0319.7541.70
Net income USD (M)-38.5573.8760.7153.42126.95
Basic EPS USD/shares-0.681.341.131.012.41
Diluted EPS USD/shares-0.681.321.040.982.36
Basic weighted shares shares (M)56.4555.1053.6753.1052.62
Diluted weighted shares shares (M)56.4555.9661.6854.3653.69
Selling, general and administrative USD (M)485.56321.58377.22304.76200.68

Supernus Pharmaceuticals Inc 주식 (SUPN) 내부자 거래

  • Rubin JonathanAug 12 '26
    SVP, Chief Medical Officer
    거래
    Option Exercise
    비용
    $0.00
    #주식
    750
    가치 ($)
    0
    #주식 총계
    14,342
  • DEC TIMOTHY CAug 12 '26
    Senior Vice-President & CFO
    거래
    Option Exercise
    비용
    $0.00
    #주식
    1,250
    가치 ($)
    0
    #주식 총계
    9,733
  • Khattar Jack A.Aug 12 '26
    President, CEO
    거래
    Option Exercise
    비용
    $0.00
    #주식
    29,849
    가치 ($)
    0
    #주식 총계
    1,270,993
  • Mottola FrankAug 12 '26
    SVP, Chief Tech. Ops. Officer
    거래
    Option Exercise
    비용
    $0.00
    #주식
    1,650
    가치 ($)
    0
    #주식 총계
    20,341
  • Sr. VP of IP, CSO
    거래
    Option Exercise
    비용
    $0.00
    #주식
    2,500
    가치 ($)
    0
    #주식 총계
    19,795
  • Sr. VP of IP, CSO
    거래
    Option Exercise
    비용
    $39.40
    #주식
    7,250
    가치 ($)
    285,650
    #주식 총계
    24,294
  • Sr. VP of IP, CSO
    거래
    Sale
    비용
    $49.60
    #주식
    7,250
    가치 ($)
    359,621
    #주식 총계
    17,044
  • Sr. VP of IP, CSO
    거래
    Option Exercise
    비용
    $38.51
    #주식
    50,000
    가치 ($)
    1,925,537
    #주식 총계
    67,044
  • Officer
    거래
    Proposed Sale
    비용
    $50.21
    #주식
    57,250
    가치 ($)
    2,874,522
    #주식 총계
    0
  • Sr. VP of IP, CSO
    거래
    Sale
    비용
    $50.30
    #주식
    50,000
    가치 ($)
    2,514,886
    #주식 총계
    17,044
내부자 거래관계날짜거래비용#주식가치 ($)#주식 총계
Rubin JonathanSVP, Chief Medical OfficerAug 12 '26Option Exercise$0.00750014,342
DEC TIMOTHY CSenior Vice-President & CFOAug 12 '26Option Exercise$0.001,25009,733
Khattar Jack A.President, CEOAug 12 '26Option Exercise$0.0029,84901,270,993
Mottola FrankSVP, Chief Tech. Ops. OfficerAug 12 '26Option Exercise$0.001,650020,341
Bhatt Padmanabh P.Sr. VP of IP, CSOAug 12 '26Option Exercise$0.002,500019,795
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 18 '26Option Exercise$39.407,250285,65024,294
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 18 '26Sale$49.607,250359,62117,044
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 17 '26Option Exercise$38.5150,0001,925,53767,044
PADMANABH P BHATTOfficerMar 17 '26Proposed Sale$50.2157,2502,874,5220
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 17 '26Sale$50.3050,0002,514,88617,044

Supernus Pharmaceuticals Inc 주식(SUPN)의 최신 뉴스

Nov 02, 2026
Nov 02, 2026
Oct 31, 2026
Oct 31, 2026
Oct 30, 2026
Oct 30, 2026
Oct 30, 2026
Oct 30, 2026
Oct 30, 2026
Oct 30, 2026
Oct 30, 2026
Oct 30, 2026
Oct 30, 2026
Oct 30, 2026
Oct 30, 2026
Oct 30, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 28, 2026
Oct 28, 2026
Oct 28, 2026
Oct 28, 2026
Oct 26, 2026
Oct 26, 2026
Oct 26, 2026
Oct 26, 2026
Oct 26, 2026
Oct 26, 2026
Oct 26, 2026
Oct 26, 2026
Oct 26, 2026
Oct 26, 2026
Oct 23, 2026
Oct 23, 2026
Oct 22, 2026
Oct 22, 2026
Oct 22, 2026
Oct 22, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 15, 2026
Oct 15, 2026
Oct 15, 2026
Oct 15, 2026
Oct 15, 2026
Oct 15, 2026
Oct 15, 2026
Oct 15, 2026
Oct 15, 2026
Oct 15, 2026
Oct 14, 2026
Oct 14, 2026
Oct 14, 2026
Oct 14, 2026
Oct 06, 2026
Oct 06, 2026
Sep 28, 2026
Sep 28, 2026
Sep 24, 2026
Sep 24, 2026
Sep 24, 2026
Sep 24, 2026

SUPN와(과) 유사한 종목